Regulatory Consulting - International is an independent consultancy that specialises in helping pharmaceutical companies optimise their regulatory activities for the Emerging Markets of Asia, Latin America, Middle East, Africa and Central and Eastern Europe. RC-I offers client companies a pragmatic regulatory service based on solid experience.

The Emerging Markets provide a tremendous opportunity for growth to the pharmaceutical sector, whether through expansion of a current company presence or through organic growth into these markets. Eighty percent of the world's population, and hence patients, are in these regions of the world.

The regulatory environment in the Emerging Markets, or International Regions, is diverse and constantly evolving to new levels of complexity. In order to advance their commercial objectives for these regions, pharmaceutical companies will be aware that their regulatory strategy is an integral part of their business strategy